Acadia Pharmaceuticals (ACAD) Inventory Average (2016 - 2026)

Acadia Pharmaceuticals has reported Inventory Average for 11 years, with the latest figure at $33.1 million in Q1 2026.

• For the quarter ending Q1 2026, Inventory Average rose 47.55% year-over-year to $33.1 million; the trailing twelve-month figure through Mar 2026 stood at $33.1 million (up 47.55% YoY), and the FY2025 full-year result was $28.3 million, down 1.99% from the prior year.
• Inventory Average for Q1 2026 stood at $33.1 million, up from $31.9 million in the prior quarter.
• The five-year high for Inventory Average was $66.7 million in Q2 2024, with the low at $6.1 million in Q3 2022.
• Average Inventory Average over 5 years is $26.3 million, with a median of $24.5 million recorded in 2025.
• Year-over-year, Inventory Average soared 772.64% in 2024 and slumped 63.23% in 2025.
• Tracing ACAD's Inventory Average over 5 years: stood at $6.2 million in 2022, then jumped by 353.42% to $28.3 million in 2023, then jumped by 46.66% to $41.5 million in 2024, then slipped by 23.16% to $31.9 million in 2025, then increased by 3.88% to $33.1 million in 2026.
• The last three Inventory Average figures came in at $33.1 million (Q1 2026), $31.9 million (Q4 2025), and $27.6 million (Q3 2025), per Business Quant data.

Peer Comparison